Aldosterone receptor antagonists: biology and novel therapeutical applications.

about

Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension.

P2860

Q37742729-F01263B2-9D26-4372-83EB-D43E5D068017 Q47648887-8B3F1F7F-08E7-43D5-BB88-450BAD0161F0

P2860

Aldosterone receptor antagonists: biology and novel therapeutical applications.

Item

http://www.wikidata.org/entity/Q35605655

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@ast

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@en

type

Item

label

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@ast

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@en

prefLabel

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@ast

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@en

P1476

Aldosterone receptor antagonists: biology and novel therapeutical applications.

@en

P2093

Magni P

http://www.w3.org/2001/XMLSchema#string

Motta M

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

Primary structure and expression of a functional human glucocorticoid receptor cDNA

Spironolactone versus nifedipine in essential hypertension

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Aldosterone production is activated in failing ventricle in humans.

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay.

Angiotensin III: a central regulator of vasopressin release and blood pressure.

Disorders of mineralocorticoid synthesis.

P2888

bf03347366

P304

788-798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/BF03347366

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14669838

http://www.w3.org/2001/XMLSchema#string

Aldosterone receptor antagonists: biology and novel therapeutical applications.

about

P2860

P2860

Aldosterone receptor antagonists: biology and novel therapeutical applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698